Radnor, Pa, February 8, 2019 – Avantor, Inc., a leading global provider of mission critical products and services to customers in the Biopharma, Healthcare, Education & Government, and Advanced Technologies & Applied Materials industries, today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (“SEC”) relating to the proposed initial public offering (“IPO”) and listing of Avantor’s common stock.
A registration statement relating to the proposed IPO has been filed with the SEC but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release does not constitute
an offer to sell or the solicitation of an offer to buy securities, and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of that jurisdiction.
About Avantor
Avantor® is a global manufacturer and distributor of high-quality products, services and solutions to professionals in the life sciences and advanced technology industries. As our channel brand, VWR offers an integrated, seamless purchasing experience that is optimized for the way our customers do business. Operating from over 30 countries worldwide, the company seeks to enable customer success in the biopharmaceutical, pharmaceutical, medical device, diagnostics, healthcare, educational, industrial, government, aerospace & defense, and semiconductor industries.
Media Contact
Allison Hosak
Senior Vice President, Global Communications
Avantor
+1 908-329-7281
Allison.Hosak@avantorsciences.com
Daniel Yunger / Liz Cohen
Kekst CNC
+1 212-521-4800
Daniel.yunger@kekstcnc.com / Liz.cohen@kekstcnc.com